Rationale and design of a study to evaluate effects of pitavastatin on Japanese patients with chronic heart failure: The pitavastatin heart failure study (PEARL study)
International Journal of Cardiology,  Clinical Article

Mizuma H et al. – The PEARL study will provide important data on the role of pitavastatin in the treatment of Japanese patients with mildly symptomatic heart failure.

Methods
  • 577 patients with chronic heart failure were enrolled.
  • Authors used a prospective, randomized, open–label, and blinded–endpoint evaluation (PROBE) design.
  • Patients aged 20–79years old with symptomatic (NYHA functional class II or III) heart failure and a left ventricular ejection fraction of ≤45% were randomly allocated to either receive pitavastatin (2mg/day) or not in addition to conventional therapy for heart failure by using the minimization method.
  • Follow–up will be continued until March 2011.

Results
  • The primary endpoint is a composite of cardiac death and hospitalization for worsening heart failure.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Physician Assistant

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Physician Assistant Articles

Indexed Journals in Physician Assistant: Advance for Physicians Assistants, American Family Physicianmore